Data Collection in Phase II-III Clinical Research – It is Ripe for Disruption?

Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems.

Why AI in Drug Discovery has Yet to Live Up to its Promise!

Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, experiments conducted. Despite rumours the age of the blockbuster...

The Highest Safety for Highly Potent Pharmaceuticals

Biotechnologically manufactured drugs are one of the most important pharmaceutical trends of the past years. Especially in cancer therapy, the advent of antibody-drug conjugates (ADCs) has opened...

CPhI expert forecasts huge growth in Middle East manufacturing with Europe a medium-term target

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing...

CRF Bracket Expands Global Reach Opening Office in Tokyo, Japan

CRF Bracket , a leading patient-centric clinical technology company, has increased its strategic investment in the Asia-Pacific Region with the opening of a new office in Tokyo, Japan.

AI in life sciences still being held back by data issues finds survey from The Pistoia Alliance

The Pistoia Alliance announced new survey results showing access to data and lack of skills are the biggest barriers to the adoption of AI and machine...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack / Editorial Calendar please click here

For the latest visit: www.worldpharmatoday.com